Advanced Glycation End Products Are Elevated in Estrogen Receptor-Positive Breast Cancer Patients, Alter Response to Therapy, and Can Be Targeted by Lifestyle Intervention

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-018-4992-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Reduced Soluble Receptor for Advanced Glycation End-Products in COPD

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Advanced Glycation End Products Are Eliminated by Scavenger-Receptor-Mediated Endocytosis in Hepatic Sinusoidal Kupffer and Endothelial Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1997English

Zinc Against Advanced Glycation End Products

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

A Receptor-Based Bioadsorbent to Target Advanced Glycation End Products in Chronic Kidney Disease

Artificial Organs
MedicineBioengineeringBiomaterialsBiomedical Engineering
2013English

Raptor Localization Predicts Prognosis and Tamoxifen Response in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Advanced Glycation End Products (AGEs) Promote Melanogenesis Through Receptor for AGEs

Scientific Reports
Multidisciplinary
2016English

Advanced Glycation End Products Can Induce Glial Reaction and Neuronal Degeneration in Retinal Explants

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Microplate-Based Assay for Screening of Advanced Glycation End Products Binding to Its Receptor

Analytical Sciences
Analytical Chemistry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy